Intelligence Platform
Patents
Browse 738 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6933306
Hydroxamic and carboxylic acid derivatives
expired patentUS 6919347
Bradykinin B1 receptor antagonists
expired patentUS 6903131
3,4-di-substituted maleimide compounds as CXC chemokine receptor antagonists
expired patentUS 6900213
Bisaryl derivatives having FSH modulatory activity
expired patentUS 6894069
Method for treating perinatal asphyxia in a human or animal neonate
expired patentUS 6887889
Aryl and biaryl piperdines with MCH modulatory activity
expired patentUS 6887865
N-heterocyclic derivatives as NOS inhibitors
expired patentUS 6884618
Identification of the gene causing the mouse scurfy phenotype and its human ortholog
expired patentUS 6878709
3,4-di-substituted pyridazinediones as CXC chemokine receptor antagonists
expired patentUS 6864368
N-heterocyclic derivatives as NOS inhibitors
expired patentUS 6864263
N-heterocyclic derivatives as NOS inhibitors
expired patentUS 6858402
System for discovering and producing polypeptides that cause TNF receptor shedding
expired patentUS 6849621
Piperidine compounds
expired patentUS 6849739
N-heterocyclic derivatives as NOS inhibitors
expired patentUS 6846829
N-heterocyclic derivatives as NOS inhibitors
expired patentUS 6841674
N-heterocyclic derivatives as NOS inhibitors
expired patentUS 6818622
Selective MMP inhibitors having reduced side-effects
expired patentUS 6809100
Hydroxamic acid derivatives
expired patentUS 6803453
Antibodies associated with alterations in bone density
expired patentUS 6794145
Identification of the gene causing the mouse scurfy phenotype and its human ortholog
expired patentUS 6787536
Hydroxamic acid derivatives
expired patentUS 6787573
Antiviral therapy
expired patentUS 6734189
Hydroxamic and carboxylic acid derivatives
expired patentUS 6730794
Substituted indolealkanoic acids
expired